OC
BMEA icon

Oppenheimer & Co’s Biomea Fusion BMEA Stock Holding History

Oppenheimer & Co’s Portfolio BMEA Stock Details BMEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-165,937
Closed -$353K – 1610
2025
Q1 		$353K Buy
165,937
+78,579
+90% +$268K 0.01% 1200
2024
Q4 		$339K Sell
87,358
-211
-0.2% -$1.68K 0.01% 1206
2024
Q3 		$884K Sell
87,569
-3,953
-4% -$25.7K 0.01% 832
2024
Q2 		$412K Buy
91,522
+77,818
+568% +$791K 0.01% 1070
2024
Q1 		$205K Sell
13,704
-11,658
-46% -$192K ﹤0.01% 1337
2023
Q4 		$368K Buy
+25,362
New +$308K 0.01% 1065
2023
Q3 		– Sell
-12,044
Closed -$264K – 1383
2023
Q2 		$264K Buy
+12,044
New +$377K 0.01% 1206

Other funds holding BMEA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Oppenheimer & Co's BMEA Position: Q2 2025 in Review

Oppenheimer & Co sold out of Biomea Fusion (BMEA) in Q2 2025, closing a stake of 165,937 shares — an estimated $353K sold.

Oppenheimer & Co first reported a position in BMEA in Q2 2023 and held it in 7 quarters. The position peaked at $884K in Q3 2024. 87 funds tracked by Wall St. Rank hold BMEA as of Q2 2025.

  • Oppenheimer & Co reported no remaining Biomea Fusion position as of Q2 2025 after selling out during the quarter.
  • Oppenheimer & Co sold 165,937 Biomea Fusion shares in Q2 2025, an estimated $353K.
  • Oppenheimer & Co first reported a position in Biomea Fusion in Q2 2023 and held it in 7 quarters.
  • Oppenheimer & Co's Biomea Fusion position peaked at $884K in Q3 2024.
  • 87 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2025.

Based on Oppenheimer & Co's 13F filing for Q2 2025, filed 31 Jul 2025.